Turin Transfer Market: A Sensational Twist for Gvidas Gineitis
Gvidas Gineitis’s situation has changed following Celtic Glasgow’s elimination in the Champions League qualifiers. The Scottish team was surprisingly knocked out by LASK Linz, which won 5-1 in extra time after losing the first leg 3-0.
Celtic had been tracking the midfielder for some time, and in the final days of the transfer window, it seemed the conditions were in place to finalize the deal. However, their exit from the Champions League has changed the landscape, and the move to Scotland is no longer expected to materialize.
Gineitis’s future may still lie away from his current team. Salzburg has emerged as a possible destination, and the player is not considered untouchable. Faced with an offer of at least 10 million euros, the club would be willing to consider a sale. The midfielder himself would also carefully consider any potential offer.
It should be noted that the relationship between Celtic and Torino had already experienced some friction in the preceding weeks: the Scots had submitted an official offer of 7.5 million euros for the Lithuanian, which was rejected by Cairo and Petrachi, who have consistently valued him at around 15 million. The British side had said they were ready to raise their offer to 10 million, but the gap with Torino’s asking price remained significant.
Gineitis, born in 2004 and a product of Torino’s youth academy, is not considered indispensable by either head coach Ignazio Abate or sporting director Gianluca Petrachi. His sale would guarantee the club a significant capital gain, which is why Torino has always been open to negotiations, while maintaining a high valuation. The player’s agent had, moreover, already publicly stated his client’s willingness to consider new opportunities, emphasizing that the midfielder was drawn to the prospect of playing on the European stage.
In addition to Salzburg, there have been inquiries in recent weeks from several Bundesliga clubs and even interest from Atalanta. The range of options for Gineitis therefore remains open, with Torino aiming to maximize the proceeds from this sale to help finance the latest signings requested by Abate.
